Patients who underwent proton beam therapy for prostate cancer reported higher quality of life in early follow-up and similar scores at two years, compared with 3D conformal therapy and intensity-modulated radiation therapy, according to research presented at the American Society for Radiation Oncology (ASTRO) annual meeting in Boston.

Radiation therapy (RT) improved survival rates among older women with early-stage, low-risk breast cancer, according to research presented at the American Society for Radiation Oncology (ASTRO) meeting in Boston. Researchers recommended that treatment guidelines be updated to include these findings.

Stereotactic body radiation therapy (SBRT) could offer patients with inoperable non-small cell lung cancer (NSCLC) higher overall survival rates with lower toxicity than conventional radiation therapy, according to research presented Oct. 29 at the American Society for Radiation Oncology (ASTRO) annual meeting in Boston.

Nordion has been granted special permission by Isotope, the authorized subsidiary of Russia’s State Atomic Energy Corporation, Rosatom, to enter into a negotiation with the Research Institute of Atomic Reactors (RIAR) for supply of Molybdenum-99 (Mo-99).

IBA Group, which develops cancer diagnosis and therapy technologies, and Royal Philips Electronics will install a patient-centered proton therapy treatment room. The addition to the Willis-Knighton Cancer Center in Shreveport, La., will incorporate the Philips Ambient Experience.

Women with aggressive breast cancer at diagnosis were more likely to receive chemotherapy, but at the expense of completing locoregional radiotherapy, according to data presented at the Fifth American Association for Cancer Research (AACR) Conference on The Science of Cancer Health Disparities in San Diego Oct. 27—30.